Tour de France: Gontchar the target for preying Landis

Favourites outpaced by Ukrainian veteran

The Tour's first major challenge, a 52-kilometre time trial, saw the American Floyd Landis make solid inroads on the overall classification and - on paper and prior to all the mountains - become the best-placed favourite for the final victory in Paris.

While the veteran Sergei Gontchar took both a surprising win on stage seven and the yellow jersey yesterday, the 36-year-old Ukrainian is widely expected to hold the lead only as far as the foot of the Pyrenees next Wednesday.

Landis, who placed an impressive second, 1min 1sec behind Gontchar, could well have ended his stage very differently after the Phonak rider was forced to change his bike mid-race following a spectacular near-crash.

Just as in the prologue, where a slit tyre meant a late start to the stage, the Pennsylvanian was teetering towards disaster at one point. He all but took off when he rode over a speed bump at full steam, his front wheel rearing in the air and his entire frame slammed against a mini-roundabout.

His handlebars broke under the impact, and it was nothing short of miraculous that Landis did not crash badly as well. Instead, the former lieutenant for Lance Armstrong has now become the best-placed of the overall contenders, second, 1min behind Gontchar.

Landis was one of the few Americans - most people's pre-stage favourites - to come away from the time trial feeling satisfied. The leader of Armstrong's Discovery team, George Hincapie, slid slowly out of the frame to take 24th, while the Californian Levi Leipheimer cracked completely to finish over six minutes down.

Bobby Julich, one of the few previous Tour podium finishers still in the race, fared even worse. The CSC rider's front wheel slipped on a greasy road surface and he left the race with a broken wrist.

The real surprise of the day, though, was Gontchar, a former world time-trial champion but who, at 36, was thought too long in the tooth to count as a contender. There was no disputing the figures though: Gontchar smashed all the intermediate best times to record the fourth fastest average speed ever at 50.554kmh for a long time trial in the Tour.

"This area must bring me luck, I won the world time-trial championships in 2000 just down the road from here," Gontchar said. "For now I don't know what will happen afterwards, I just want to enjoy the feeling of taking my first ever stage in the Tour.

"Yes I am 36, but I feel a lot younger." Age notwithstanding, Gontchar could prove difficult for Landis to shake off in the mountains. Second in the 2004 Giro d'Italia and briefly leader in the same race earlier this season, the Ukrainian has a string of top-10 overall places in Italy's top event to his name, and his team have four riders in the first 10 in the Tour.

For T-Mobile, Gontchar's yellow jersey is a near-miracle: their leader Jan Ullrich was excluded from the Tour in the build-up following implication in a doping scandal, and the team's morale was understandably battered as a consequence.

While one of Britain's time-trial specialists on the race, David Millar, suffered badly to finish a disappointing 37th, his compatriot Bradley Wiggins celebrated his Tour debut with 28th on the stage.

"I nearly cracked in the last two kilometres, but I'm very pleased," Wiggins, who beat stars of the calibre of Hincapie and Leipheimer, said. "I was supposed to go all out in the first part and then ease off, but in fact I was going so well I ended up catching two other riders."

Alasdair Fotheringham writes for 'Cycling Weekly'

Have you tried new the Independent Digital Edition apps?
Caption competition
Caption competition
  • Get to the point
Latest stories from i100
Daily Quiz
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

Career Services
iJobs Job Widget
iJobs General

Ashdown Group: Marketing Manager (B2B) - Romford - £40,000 + car

£35000 - £40000 per annum + car and benefits: Ashdown Group: Marketing Manager...

Ashdown Group: Helpdesk Analyst - Devon - £20,000

£18000 - £20000 per annum: Ashdown Group: Helpdesk Analyst - Devon - £20,000 ...

Ashdown Group: Data Scientist - London - £50,000 + bonus

£35000 - £50000 per annum + generous bonus: Ashdown Group: Business Analytics ...

Ashdown Group: IT Project Coordinator (Software Development) - Kingston

£45000 - £50000 per annum: Ashdown Group: IT Project Coordinator (Software Dev...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'